Charts

LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter of 2024 ended March 31, 2024 before the market opens on Tuesday, May 7, 2024. The Company will host a conference call and audio webcast that morning at 8:30 a

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers NKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's regular session. The company's market cap stands at ...

Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session. The company announced its third-quarter ...

Gainers Mobile-health Network (NASDAQ:MNDR) shares increased by 34.7% to $27.44 during Friday's regular session. The market value of ...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 100 points on Friday. Following the market opening ...

Gainers Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a ...

Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market ...

Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday's regular session. The market value of their ...

Gainers IN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday's pre-market session. The market value of their ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We are diving into the biggest pre-market stock movers with all of the most recent news worth reading about on Thursday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of “America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out It doesn’t matter if you have $500 or $5 million. Do this now.

iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript March 14, 2024 iSpecimen Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to iSpecimen’s Full-Year 2023 Results Conference Call. At this time, all participants are in […]

iSpecimen ( NASDAQ:ISPC ) Full Year 2023 Results Key Financial Results Revenue: US$9.93m (down 4.6% from FY 2022). Net...

LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2023. “Throughout 2023, we advanced our objective to reach profitability, focusing on right-sizing our business and implementing new operati

iSpecimen (NASDAQ:ISPC) reported its Q4 earnings results on Wednesday, March 13, 2024 at 05:28 PM. Here's what investors need to know ...

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share ...

The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am EasternLEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended D

iSpecimen (NASDAQ:ISPC) is set to give its latest quarterly earnings report on Wednesday, 2024-03-13. Here's what investors need to know ...

LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended December 31, 2023 before the market opens on Wednesday, March 13, 2024. The Company will host a conference call and audio webcast that morning at 8:30 a.m.

Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology ServicesLEXINGTON, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it entered into a pilot program agreement with TriMetis Life Sciences, LLC (“TriMetis”), a provider of digital pathol

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 24th, & Thursday, January 25th, 2024, starting at 9:00 a.m. ET. We will be presenting our 2024 Healthcare IT Virtual Conference. Allen Klee, Senior Research Analyst at Maxim Grou

LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will be participating in the Maxim Group Virtual Healthcare IT Conference on January 25, 2024. Tracy Curley, Chief Executive Officer, will present at 10:00 a.m. ET. To access the presentation, please use the followi

Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology ResearchLEXINGTON, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the addition of several new suppliers, expanded relationships wit

iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call. At this time, participants are in listen-only mode. Question-and-answer session will follow management’s remarks. This conference call is being recorded. A replay of today’s call will be available on the […]

Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business InitiativesLEXINGTON, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and nine month periods

New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom ProjectsLEXINGTON, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for biomedical research with a network of healthcare specimen providers, announced today that the Company has added several new infectious disease specimen providers to its global supply network. These

Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares rose 30.0% to $2.34 during Wednesday's regular session. As of 13:30 EST, this ...

Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today preliminary financial results for the third quarter of 2023. The Company expects third quarter 2023 revenue to be between $2.6 to $2.8 milli

Gainers Immunic (NASDAQ:IMUX) shares moved upwards by 28.3% to $2.04 during Monday's after-market session. Trading volume for this ...

Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical ResearchLEXINGTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for biomedical research with a network of healthcare specimen providers, announced today that the Company has added a new next-day quote service for researchers and providers. Tailored to accelerate the

In a recent development, Benjamin Bielak, Chief Information Officer & Secretary of iSpecimen Inc (NASDAQ:ISPC), purchased 18,000 shares of the company on September 14, 2023.

Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIsLEXINGTON, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has re

Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense ReductionsLEXINGTON, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that the Board of Directors has approved an organizational restructurin

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum ...

Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutations LEXINGTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the launch of a new

New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and Facilitate Automated, Instant Matchmaking for Researcher RequestsLEXINGTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that the Company has enhanced its proprietary Market

Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 32.2% to $2.46 during Thursday's pre-market session. The market value of their ...

Benzinga Pro data, iSpecimen (NASDAQ:ISPC) reported Q1 sales of $2.95 million. Earnings fell to a loss of $2.43 million, resulting in a ...

iSpecimen (NASDAQ:ISPC) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM. Here's what investors need to know about ...

iSpecimen (NASDAQ:ISPC) is set to give its latest quarterly earnings report on Tuesday, 2023-03-14. Here's what investors need to know ...

Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The ...

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ...

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares jumped 97% to $4.71 after the company and Seagen Inc (NASDAQ: SGEN) ...

Gainers RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 31.4% to $0.6525 in pre-market trading after dipping over 20% on Friday. The ...

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Total Stock Market ETF (VTI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $241.91 per unit.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's time for another look at the biggest pre-market stock movers as we see why shares are moving Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Total Stock Market ETF (VTI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $244.41 per unit.

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the ...

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday ...

iSpecimen Inc(NASDAQ: ISPC) hasadded new global biospecimen suppliersto its proprietary Marketplace platform for ...

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $179.75 per unit.